[HTML][HTML] A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
P Thomas, B Vincent, C George… - Indian Journal of …, 2019 - journals.lww.com
Methods: This study included 71 NSCLC patients who received EGFR-TKIs between 2013
and 2016. Adverse drug reaction of both erlotinib (n= 37) and gefitinib (n= 34) was …
and 2016. Adverse drug reaction of both erlotinib (n= 37) and gefitinib (n= 34) was …
A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients.
P Thomas, B Vincent, C George, JM Joshua… - The Indian Journal of …, 2019 - europepmc.org
Background & objectives: Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth
factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung …
factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung …
A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
P Thomas, B Vincent, C George… - The Indian journal …, 2019 - pubmed.ncbi.nlm.nih.gov
Background & objectives Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth
factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung …
factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung …
A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
T Preenumol, V Bini, C George… - The Indian Journal …, 2019 - search.proquest.com
Background & objectives: Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth
factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung …
factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung …
[HTML][HTML] A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
P Thomas, B Vincent, C George… - The Indian Journal of …, 2019 - ncbi.nlm.nih.gov
Methods: This study included 71 NSCLC patients who received EGFR-TKIs between 2013
and 2016. Adverse drug reaction of both erlotinib (n= 37) and gefitinib (n= 34) was …
and 2016. Adverse drug reaction of both erlotinib (n= 37) and gefitinib (n= 34) was …
A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients.
P Thomas, B Vincent, C George… - Indian Journal of …, 2019 - search.ebscohost.com
Background & objectives: Tyrosine kinase inhibitors (TKIs) targeting the epidermal
growth factor receptor (EGFR) have been evaluated in patients with advanced non-small cell …
growth factor receptor (EGFR) have been evaluated in patients with advanced non-small cell …
A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
P Thomas, B Vincent, C George, JM Joshua… - 2019 - pesquisa.bvsalud.org
objectives: Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth factor receptor
(EGFR) have been evaluated in patients with advanced non-small cell lung cancer …
(EGFR) have been evaluated in patients with advanced non-small cell lung cancer …
A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients.
P Thomas, B Vincent, C George, J Joshua… - Indian Journal of …, 2019 - go.gale.com
Background & objectives: Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth
factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung …
factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung …
A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients.
P Thomas, B Vincent, C George, JM Joshua… - The Indian Journal of …, 2019 - europepmc.org
Background & objectives: Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth
factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung …
factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung …
A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients
P Thomas, B Vincent, C George, JM Joshua… - 2019 - pesquisa.bvsalud.org
objectives: Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth factor receptor
(EGFR) have been evaluated in patients with advanced non-small cell lung cancer …
(EGFR) have been evaluated in patients with advanced non-small cell lung cancer …